HQL vs. BCAT
HQL (Tekla Life Sciences Investors) and BCAT (BlackRock Capital Allocation Term Trust) are both stocks. Both are in the Financial Services sector — HQL in Asset Management, BCAT in Capital Markets. Over the past 5 years, HQL returned 9.74%/yr vs 8.45%/yr for BCAT. Their 0.45 correlation means their historical movements had little consistent relationship.
Performance
HQL vs. BCAT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HQL achieves a 25.27% return, which is significantly lower than BCAT's 27.49% return.
HQL
- 1D
- 2.23%
- 1M
- -2.09%
- 6M
- 22.43%
- YTD
- 25.27%
- 1Y
- 67.53%
- 3Y*
- 28.98%
- 5Y*
- 9.74%
- 10Y*
- 10.15%
- ALL TIME*
- 8.70%
BCAT
- 1D
- 1.07%
- 1M
- 3.36%
- 6M
- 21.56%
- YTD
- 27.49%
- 1Y
- 32.41%
- 3Y*
- 21.82%
- 5Y*
- 8.45%
- 10Y*
- —
- ALL TIME*
- 9.48%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $10.10M | $12.16M | $11.31M | |
| $3.56M | $3.20M | $2.54M |
HQL vs. BCAT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
HQL Tekla Life Sciences Investors | 25.27% | 45.48% | 11.03% | 4.23% | -19.21% | 5.52% | 18.90% |
BCAT BlackRock Capital Allocation Term Trust | 27.49% | 16.78% | 19.37% | 19.30% | -22.64% | -5.21% | 9.35% |
Correlation
The correlation between HQL and BCAT is 0.39, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.39 |
Correlation (3Y) Balances recent behavior with more history. | 0.41 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.48 |
Correlation (All Time) Calculated using the full available price history since Sep 25, 2020 | 0.45 |
Fundamentals
HQL:
$599.04M
BCAT:
$1.68B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HQL vs. BCAT — Risk / Return Rank
HQL
BCAT
HQL vs. BCAT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Tekla Life Sciences Investors (HQL) and BlackRock Capital Allocation Term Trust (BCAT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| HQL | BCAT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.43 | ||
| Sortino ratioReturn per unit of downside risk | +0.26 | ||
| Omega ratioGain probability vs. loss probability | 1.49 | 1.47 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | 6.62 | 4.08 | +2.54 |
| Martin ratioReturn relative to average drawdown | 19.18 | 18.25 | +0.92 |
Loading charts...
Drawdowns
HQL vs. BCAT - Drawdown Comparison
The maximum HQL drawdown since its inception was -62.65%, which is greater than BCAT's maximum drawdown of -36.13%. Use the drawdown chart below to compare losses from any high point for HQL and BCAT.
Loading charts...
Drawdown Indicators
| HQL | BCAT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -62.65% | -36.13% | -26.52% |
Max Drawdown (1Y)Largest decline over 1 year | -10.25% | -7.98% | -2.27% |
Max Drawdown (3Y)Largest decline over 3 years | -25.10% | -13.69% | -11.41% |
Max Drawdown (5Y)Largest decline over 5 years | -38.86% | -33.67% | -5.19% |
Max Drawdown (10Y)Largest decline over 10 years | -38.86% | — | — |
Current DrawdownCurrent decline from peak | -5.42% | 0.00% | -5.42% |
Average DrawdownAverage peak-to-trough decline | -22.17% | -12.46% | -9.71% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.53% | 1.78% | +1.75% |
Volatility
HQL vs. BCAT - Volatility Comparison
Tekla Life Sciences Investors (HQL) has a higher volatility of 6.72% compared to BlackRock Capital Allocation Term Trust (BCAT) at 3.86%. This indicates that HQL's price experiences larger fluctuations and is considered to be riskier than BCAT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HQL | BCAT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.72% | 3.86% | +2.86% |
Volatility (6M)Calculated over the trailing 6-month period | 15.67% | 9.91% | +5.76% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.77% | 12.12% | +9.65% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.93% | 15.21% | +5.72% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.28% | 15.88% | +6.40% |
Dividends
HQL vs. BCAT - Dividend Comparison
HQL's dividend yield for the trailing twelve months is around 10.36%, less than BCAT's 19.63% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BCAT BlackRock Capital Allocation Term Trust | 19.63% | 23.45% | 17.48% | 10.08% | 9.01% | 6.42% | 0.48% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
HQL Tekla Life Sciences Investors | 10.36% | 10.85% | 14.18% | 9.44% | 9.57% | 8.79% | 7.90% | 8.03% | 10.72% | 8.25% | 12.18% | 11.84% |
Financials
HQL vs. BCAT - Financials Comparison
This section allows you to compare key financial metrics between Tekla Life Sciences Investors and BlackRock Capital Allocation Term Trust. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
HQL and BCAT have a correlation of 0.39, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HQL has higher volatility (6.72%) compared to BCAT (3.86%). In terms of maximum drawdown, HQL dropped -62.65% vs BCAT's -36.13%.
HQL currently has the higher Sharpe Ratio (3.12 vs 2.69), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HQL and BCAT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer